OA
OGN icon

Operose Advisors’s Organon & Co OGN Stock Holding History

Operose Advisors’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$217 Buy
+16
New +$191 ﹤0.01% 517
2022
Q1 		– Sell
-2
Closed – – 333
2021
Q4 		$0 Buy
+2
New +$65 ﹤0.01% 299

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Operose Advisors's OGN Position: Q2 2026 in Review

Operose Advisors opened a new position in Organon & Co (OGN) in Q2 2026: 16 shares worth $217. The stake represents ﹤0.01% of the portfolio and ranks #517 among its holdings. This is a return to the name: Operose Advisors previously reported a position in OGN as recently as Q4 2021.

Operose Advisors first reported a position in OGN in Q4 2021 and has held it in 2 quarters since. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Operose Advisors held 16 shares of Organon & Co worth $217 as of Q2 2026.
  • Organon & Co was a new Operose Advisors position in Q2 2026.
  • Organon & Co made up ﹤0.01% of Operose Advisors's portfolio in Q2 2026, its #517 holding.
  • Operose Advisors first reported a position in Organon & Co in Q4 2021 and has held it in 2 quarters since.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Operose Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.